Skip to Main Content

Paper Details

No difference in cardiovascular risk of tocilizumab versus abatacept for rheumatoid arthritis: A multi-database cohort study.
Semin Arthritis Rheum
28
2018
Author NameAffiliation
James R RogersDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Sebastian SchneeweissDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
  • 1 - 2

Datasets

Release 1.2